Q-omics provides the consensus-scored CCDC195 profile across patient tissues and cancer cell-line models. Additionally, CCDC195 RNA expression shows 5,679 significant protein co-abundance associations, with the highest sampling consensus in LUAD.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for CCDC195 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with CCDC195 in patient tissues and cancer cell lines. In patient samples, CCDC195 shows the broadest associations at the RNA and protein expression levels, with LUAD recurring as the lineage with the largest associated feature set. In cancer cell lines, CCDC195 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in BLOOD_Lymphoma.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	5,679	LUAD (2016)	view →
Function (mass-spec)	502	LUAD (156)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	2,597	BLOOD_Lymphoma (1441)	view →
Function (RNA)	1,022	BLOOD_Lymphoma (741)	view →